Practice
High-dose influenza vaccination
Daniel Dalcin and Jeffrey C. Kwong
CMAJ March 18, 2019 191 (11) E313; DOI: https://doi.org/10.1503/cmaj.181477
Daniel Dalcin
Faculty of Medicine (Dalcin), Dalhousie University, Halifax, NS; ICES (Kwong); Public Health Ontario (Kwong); Department of Family and Community Medicine (Kwong), University of Toronto, Toronto, Ont.
MDJeffrey C. Kwong
Faculty of Medicine (Dalcin), Dalhousie University, Halifax, NS; ICES (Kwong); Public Health Ontario (Kwong); Department of Family and Community Medicine (Kwong), University of Toronto, Toronto, Ont.
MD MScData supplements
Podcast
Related Articles
In this issue
Article tools
High-dose influenza vaccination
Daniel Dalcin, Jeffrey C. Kwong
CMAJ Mar 2019, 191 (11) E313; DOI: 10.1503/cmaj.181477
Jump to section
- Article
- High-dose influenza vaccine contains 4 times the amount of antigen of standard-dose vaccines
- In older adults, HD-TIV is more efficacious than SD-TIV
- HD-TIV is associated with reduced hospital admissions and emergency department visits in older adults
- HD-TIV is associated with reduced post-influenza deaths among older adults
- Mild adverse events occur more often with HD-TIV than with SD-TIV
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.
Podcast